BIBR 277 Capsules in Hypertensive Patients With Nephropathy

Randomized Study of Extended Treatment With Firibastat in Treatment-Resistant Hypertension (REFRESH)

NCT04857840 ·Status: TERMINATED ·Phase: PHASE3

Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 Diabetes

NCT00240422 ·Status: COMPLETED ·Phase: PHASE4

Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years)

NCT01415531 ·Status: COMPLETED ·Phase: PHASE4

An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination

NCT00618774 ·Status: COMPLETED ·Phase: PHASE3

Blood Pressure Control of Nifedipine GITS 60mg Treatment in Chinese Hypertensive Subjects Uncontrolled on Starting-dose Mono-therapyo-therapy.

NCT02413515 ·Status: COMPLETED ·Phase: PHASE4

Effect of the Angiotensin II Receptor Antagonist Irbesartan on Biochemical and Functional Markers of Endothelial Dysfunction in Patients With Hypertension

NCT00529750 ·Status: COMPLETED ·Phase: PHASE4

SER100 in Isolated Systolic Hypertension

NCT01987284 ·Status: COMPLETED ·Phase: PHASE2

Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney Function

NCT06775834 ·Status: COMPLETED ·Phase: PHASE1

Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension

NCT00095394 ·Status: COMPLETED ·Phase: PHASE3

ACTUAL: Efficacy and Safety of Irbesartan/Hydrochlorothiazide Combination

NCT00708344 ·Status: COMPLETED ·Phase: PHASE4

Tirzepatide in Idiopathic Intracranial Hypertension Trial

NCT07191873 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

I SAVE - Irbesartan in Mild to Moderate Hypertensive Patients

NCT00335673 ·Status: COMPLETED ·Phase: PHASE4

Nifedipine GITS and Amlodipine Besylate on Recovery of Blood Pressure Rhythm and Arterial Stiffness

NCT02940548 ·Status: TERMINATED ·Phase: PHASE4

Recurrent Stroke Prevention Clinical Outcome Study

NCT01198496 ·Status: UNKNOWN ·Phase: PHASE4

Irbesartan/Hydrochlorothiazide to Control Elevated Blood Pressure to Target in Moderate to Severe Hypertensive Patients

NCT00670566 ·Status: COMPLETED ·Phase: PHASE4

A Study of Single Dose MK-3614 (MK-3614-001)(COMPLETED)

NCT01104545 ·Status: COMPLETED ·Phase: PHASE1

A Study to Determine the Effectiveness and Tolerability of MK8141 in Patients With High Blood Pressure (MK-8141-006)

NCT00543413 ·Status: COMPLETED ·Phase: PHASE2

Safety and Effect of Oral Doses of 5mg or 10mg of SLx-2101 for 14 Days in Patients With Hypertension

NCT00562614 ·Status: COMPLETED ·Phase: PHASE2

Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria

NCT00095290 ·Status: COMPLETED ·Phase: PHASE4

Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypetension

NCT04488978 ·Status: COMPLETED ·Phase: PHASE2

Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With Microalbuminuria

NCT00561964 ·Status: COMPLETED ·Phase: PHASE3

A Study to Investigate Tonlamarsen for the Treatment of Adults With Uncontrolled Hypertension (KARDINAL)

NCT06864104 ·Status: COMPLETED ·Phase: PHASE2

The SAPPHIRE Study (Systolic And Pulse Pressure Hemodynamic Improvement By Restoring Elasticity)

NCT00045981 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension

NCT04959305 ·Status: COMPLETED ·Phase: PHASE2

Irbesartan-Hydrochlorothiazide Phase IV Study: Treatment of Hypertension in Chinese Population

NCT00847834 ·Status: COMPLETED ·Phase: PHASE4